Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

    Get Diamond plan for FREE

    logo

    Quantum-Si incorporated (QSI)

    Price:

    1.29 USD

    ( - -0.11 USD)

    Your position:

    0 USD

    ACTION PANEL
    CREATE A NOTE
    ABOUT
    Symbol
    QSI
    Name
    Quantum-Si incorporated
    Industry
    Biotechnology
    Sector
    Healthcare
    Price
    1.290
    Market Cap
    252.262M
    Enterprise value
    350.336M
    Currency
    USD
    Ceo
    Jeffrey Alan Hawkins
    Full Time Employees
    149
    Ipo Date
    2020-11-13
    City
    Guilford
    Address
    530 Old Whitfield Street

    Check the

    KEY TAKEAWAYS

    ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
    Descriptive alt text

    (REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION

    SIMILAR COMPANIES STI SCORE

    Similar STI Score

    Regeneron Pharmaceuticals, Inc.

    VALUE SCORE:

    6

    Symbol
    REGN
    Market Cap
    76.562B
    Industry
    Biotechnology
    Sector
    Healthcare

    2nd position

    ADMA Biologics, Inc.

    VALUE SCORE:

    11

    Symbol
    ADMA
    Market Cap
    4.706B
    Industry
    Biotechnology
    Sector
    Healthcare

    The best

    Genmab A/S

    VALUE SCORE:

    11

    Symbol
    GMAB
    Market Cap
    122.622B
    Industry
    Biotechnology
    Sector
    Healthcare
    FUNDAMENTALS
    P/E
    -2.225
    P/S
    73.934
    P/B
    1.072
    Debt/Equity
    0.050
    EV/FCF
    -2.503
    Price to operating cash flow
    -1.000
    Price to free cash flow
    -1.000
    EV/sales
    70.696
    Earnings yield
    -0.449
    Debt/assets
    0.044
    FUNDAMENTALS
    Net debt/ebidta
    0.104
    Interest coverage
    0
    Research And Developement To Revenue
    18.197
    Intangile to total assets
    0
    Capex to operating cash flow
    -0.043
    Capex to revenue
    1.168
    Capex to depreciation
    0.935
    Return on tangible assets
    -0.418
    Debt to market cap
    0.044
    Piotroski Score
    3.000
    FUNDAMENTALS
    PEG
    -0.022
    P/CF
    -2.564
    P/FCF
    -2.618
    RoA %
    -41.846
    RoIC %
    -49.131
    Gross Profit Margin %
    53.165
    Quick Ratio
    9.266
    Current Ratio
    9.429
    Net Profit Margin %
    -3.120k
    Net-Net
    1.018
    FUNDAMENTALS PER SHARE
    FCF per share
    -0.525
    Revenue per share
    0.019
    Net income per share
    -0.580
    Operating cash flow per share
    -0.503
    Free cash flow per share
    -0.525
    Cash per share
    1.167
    Book value per share
    1.203
    Tangible book value per share
    1.203
    Shareholders equity per share
    1.203
    Interest debt per share
    0.061
    TECHNICAL
    52 weeks high
    5.770
    52 weeks low
    0.950
    Current trading session High
    1.430
    Current trading session Low
    1.290
    DIVIDEND
    Dividend yield
    0.00%
    Payout ratio
    0.00%
    Years of div. Increase
    0
    Years of div.
    0
    Q-shift
    Dividend per share
    0
    SIMILAR COMPANIES
    logo

    Country
    CH
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -3.470
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -5.600
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -3.936
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -3.737
    logo

    Country
    GB
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -1.881
    logo

    Country
    FR
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -2.817
    logo

    Country
    CA
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -10.038
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -1.076
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -1.572
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -3.313
    DESCRIPTION

    Quantum-Si incorporated, a life sciences company, develops a single molecule detection platform for sample preparation and sequencing. It offers a proprietary single molecule detection platform for use in semiconductor industry to field proteomics to enable next generation protein sequencing. The company was incorporated in 2013 is based in Guilford, Connecticut.

    NEWS
    https://images.financialmodelingprep.com/news/quantumsi-nasdaqqsi-iqe-otcmktsiqepf-headtohead-contrast-20251129.png
    Quantum-Si (NASDAQ:QSI) & IQE (OTCMKTS:IQEPF) Head-To-Head Contrast

    defenseworld.net

    2025-11-29 01:39:04

    IQE (OTCMKTS:IQEPF - Get Free Report) and Quantum-Si (NASDAQ: QSI - Get Free Report) are both small-cap computer and technology companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, earnings, analyst recommendations, risk, profitability and valuation. Profitability This table compares IQE and Quantum-Si's

    https://images.financialmodelingprep.com/news/quantumsi-highlights-significant-development-advancements-for-proteus-and-industry-20251120.jpg
    Quantum-Si Highlights Significant Development Advancements for Proteus™ and Industry Leading Technology Pipeline at Investor & Analyst Day

    businesswire.com

    2025-11-20 08:00:00

    BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Highlights Significant Development Advancements for ProteusTM and Industry Leading Technology Pipeline at Investor & Analyst Day.

    https://images.financialmodelingprep.com/news/quantumsi-incorporated-qsi-analystinvestor-day-transcript-20251119.jpg
    Quantum-Si incorporated (QSI) Analyst/Investor Day Transcript

    seekingalpha.com

    2025-11-19 18:43:27

    Quantum-Si incorporated ( QSI ) Analyst/Investor Day November 19, 2025 10:00 AM EST Company Participants Jeffrey Hawkins - President, CEO & Director Todd Rearick - Chief Technology Officer John Vieceli - Chief Product Officer Brian Reed Conference Call Participants Kyle Mikson - Canaccord Genuity Corp., Research Division Swayampakula Ramakanth - H.C. Wainwright & Co, LLC, Research Division Scott Henry - Alliance Global Partners, Research Division Puneet Souda - Leerink Partners LLC, Research Division Presentation Jeffrey Hawkins President, CEO & Director All right.

    https://images.financialmodelingprep.com/news/quantumsi-to-highlight-significant-proteus-platform-development-progress-and-20251119.jpg
    Quantum-Si to Highlight Significant Proteus™ Platform Development Progress and Provide Insights into the Company's Industry Leading Technology Pipeline at Investor & Analyst Day

    businesswire.com

    2025-11-19 08:00:00

    BRANFORD, Conn.--(BUSINESS WIRE)--QSI to Highlight Significant Proteus™ Platform Dev Progress & Provide Insights into Company's Industry Leading Tech Pipeline at Investor & Analyst Day.

    https://images.financialmodelingprep.com/news/head-to-head-comparison-quantumsi-nasdaqqsi-vs-sequans-communications-20251115.jpg
    Head to Head Comparison: Quantum-Si (NASDAQ:QSI) vs. Sequans Communications (NYSE:SQNS)

    defenseworld.net

    2025-11-15 02:36:53

    Quantum-Si (NASDAQ: QSI - Get Free Report) and Sequans Communications (NYSE: SQNS - Get Free Report) are both small-cap computer and technology companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, profitability, risk, dividends, earnings and valuation. Profitability This table compares Quantum-Si and

    https://images.financialmodelingprep.com/news/quantumsi-incorporated-qsi-q3-2025-earnings-call-transcript-20251105.jpg
    Quantum-Si incorporated (QSI) Q3 2025 Earnings Call Transcript

    seekingalpha.com

    2025-11-05 23:01:11

    Quantum-Si incorporated ( QSI ) Q3 2025 Earnings Call November 5, 2025 4:30 PM EST Company Participants Risa Lindsay Jeffrey Hawkins - President, CEO & Director Jeffry Keyes - CFO & Treasurer Conference Call Participants Alexander Vukasin - Canaccord Genuity Corp., Research Division Scott Henry - Alliance Global Partners, Research Division Swayampakula Ramakanth - H.C. Wainwright & Co, LLC, Research Division Presentation Operator Good day, and thank you for standing by.

    https://images.financialmodelingprep.com/news/quantumsi-incorporated-qsi-reports-q3-loss-lags-revenue-estimates-20251105.jpg
    Quantum-Si Incorporated (QSI) Reports Q3 Loss, Lags Revenue Estimates

    zacks.com

    2025-11-05 20:50:47

    Quantum-Si Incorporated (QSI) came out with a quarterly loss of $0.17 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.18 per share a year ago.

    https://images.financialmodelingprep.com/news/quantumsi-reports-third-quarter-2025-financial-results-20251105.jpg
    Quantum-Si Reports Third Quarter 2025 Financial Results

    businesswire.com

    2025-11-05 16:05:00

    BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Reports Third Quarter 2025 Financial Results. Announces Successful Sequencing on Prototype Proteus Unit, Development Program is On-Track.

    https://images.financialmodelingprep.com/news/reviewing-quantumsi-nasdaqqsi-and-cirrus-logic-nasdaqcrus-20251105.png
    Reviewing Quantum-Si (NASDAQ:QSI) and Cirrus Logic (NASDAQ:CRUS)

    defenseworld.net

    2025-11-05 02:30:51

    Cirrus Logic (NASDAQ: CRUS - Get Free Report) and Quantum-Si (NASDAQ: QSI - Get Free Report) are both computer and technology companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, dividends, earnings, risk, analyst recommendations, valuation and profitability. Profitability This table compares Cirrus Logic and

    https://images.financialmodelingprep.com/news/sumitomo-mitsui-trust-group-inc-reduces-stock-position-in-20251030.jpeg
    Sumitomo Mitsui Trust Group Inc. Reduces Stock Position in Quantum-Si Incorporated $QSI

    defenseworld.net

    2025-10-30 04:06:50

    Sumitomo Mitsui Trust Group Inc. reduced its holdings in shares of Quantum-Si Incorporated (NASDAQ: QSI) by 3.3% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,621,303 shares of the company's stock after selling 190,127 shares during the quarter. Sumitomo Mitsui

    https://images.financialmodelingprep.com/news/quantumsi-to-participate-in-the-canaccord-genuity-medtech-diagnostics-20251020.jpg
    Quantum-Si to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

    businesswire.com

    2025-10-20 08:00:00

    BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum.

    https://images.financialmodelingprep.com/news/quantumsi-to-report-third-quarter-2025-financial-results-on-november-20251013.jpg
    Quantum-Si to Report Third Quarter 2025 Financial Results on November 5, 2025

    businesswire.com

    2025-10-13 08:00:00

    BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si to Report Third Quarter 2025 Financial Results on November 5, 2025.

    https://images.financialmodelingprep.com/news/why-quantumsi-stock-flopped-on-friday-20251010.jpg
    Why Quantum-Si Stock Flopped on Friday

    fool.com

    2025-10-10 16:35:00

    Quantum-Si's (QSI -4.02%) shares weren't quite the picture of health as the trading week came to an end. Investors, concerned about the healthcare technology company potentially making dilutive secondary share issues, traded out of the stock to leave it with a nearly 5% loss on the day.

    https://images.financialmodelingprep.com/news/quantumsi-to-host-investor-analyst-event-in-new-york-city-20250923.jpg
    Quantum-Si to Host Investor & Analyst Event in New York City on November 19, 2025

    businesswire.com

    2025-09-23 08:00:00

    BRANFORD, Conn--(BUSINESS WIRE)--Quantum-Si to Host Investor & Analyst Event in New York City on November 19, 2025.

    https://images.financialmodelingprep.com/news/quantumsi-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-20250915.jpg
    Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    businesswire.com

    2025-09-15 16:05:00

    BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).